GL1X · GenesisL1 explorer

Research workbench

1XT9: Crystal Structure of Den1 in complex with Nedd8

Analyse 1XT9: Crystal Structure of Den1 in complex with Nedd8 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1XT9
Type
protein
Length
284 residues
Chains
2
Method
x-ray diffraction
Authors
Reverter, D., Wu, K., Erdene, T.G., Pan, Z.Q., Wilkinson, K.D., Lima, C.D.
Deposited
10/21/04
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.2
Source
Homo sapiens
Molecule
Sentrin-specific protease 8; Neddylin
EC
3.4.22.-
UniProt
Q96LD8, Q15843
Pockets
2 · best druggability 0.47

Structure

x-ray diffraction · resolution 2.2 · 2 distinct chains · 38% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASentrin-specific protease 8 (EC 3.4.22.-)protein20844% helix, 19% strandQ96LD8
BNeddylinprotein7620% helix, 38% strandQ15843

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11360.470.7826empty
2640.350.7822empty

Interfaces

1 interface between chains.

  • A–B · 1584 Ų buried · 30 hydrogen bonds · protein-protein

Compared structures

  • 1XT9 · Crystal structure of DEN1 in complex with NEDD8 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q96LD8 · AlphaFold monomer V2.0 prediction for sentrin-specific protease 8 (Q96LD8) · a predicted model of the same protein · chain A against A, TM-score 0.97
  • Q15843 · AlphaFold monomer V2.0 prediction for NEDD8 (Q15843) · a predicted model of the same protein · chain B against A, TM-score 0.94

Analyse

Other records of 1XT9

  • 1XT9-2 · MolNFT v1 / PDB · Crystal structure of DEN1 in complex with NEDD8

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.